Haleos Labs Ltd.

•

haleoslabs.comBSE: 540679NSE: HALEOSLABS

Market Cap₹ 460 Cr.

Current Price

High / Low₹ 1,774 / 1,091

Stock P/E29.1

Book Value₹ 712

Price to Book1.66

Dividend Yield0.10 %

ROCE12.6 %

ROE10.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has consistently been profitable over the last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.00x)
Working capital cycle has improved - days down from 12 to 8
Company generates healthy free cash flow
Company has a consistent dividend-paying track record
Company maintains a comfortable, low leverage position

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 6.9% over last 3 years
Company has a low return on capital employed of 9.8%
Company has delivered a poor sales growth of 5.7% over past five years
Growth is decelerating - 3Y profit CAGR (-9.5%) trails the 5Y trend (13.0%)
Though reporting repeated profits, the company pays out little dividend (2.3%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.80	37.69	455825.66	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9305.00	84.45	247018.51	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4913.00	85.68	186874.73	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1155.00	25.53	115211.69	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1395.95	33.46	112773.00	0.93	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1868.25	92.32	100943.83	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2105.00	17.41	96254.46	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2322.05	46.95	95911.14	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1145.00	29.66	95570.85	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1658.00	25.70	95397.65	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2462.00	38.65	69483.71	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	HALEOSLABS	1520.00	29.08	459.54	0.10	1.84	-58.01	72.94	-11.60	12.60	12.50

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	75	69	72	90	93	78	85	89	83	81	95	75	73
	72	61	63	79	76	70	72	82	71	68	81	71	70
Operating Profit	3	8	9	11	16	9	13	7	12	14	14	4	3
OPM %	3.39%	11.35%	12.89%	12.62%	17.60%	10.91%	15.07%	8.33%	14.20%	16.68%	14.81%	5.54%	4.08%
	1	0	1	2	0	2	0	2	1	0	0	2	0
Interest	2	3	2	3	2	2	2	2	2	2	2	1	2
Depreciation	4	4	4	4	4	4	4	4	4	4	4	4	4
Profit before Tax	-3	2	4	7	11	5	7	4	7	8	9	1	3
Tax %	-40.29%	126.51%	-8.14%	8.87%	33.27%	29.79%	29.77%	11.45%	37.61%	24.38%	24.26%	61.54%	46.48%
Net Profit	0	0	0	0	7	3	5	3	4	6	7	0	2
	-5.94	2.24	14.24	19.53	22.99	15.46	18.08	9.83	13.75	20.19	21.89	1.44	8.75

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	378	261	266	350	316	306	345	324
	343	235	235	316	287	275	300	289
Operating Profit	35	25	30	35	29	31	45	35
OPM %	9.20%	9.74%	11.39%	9.86%	9.13%	10.20%	13.08%	10.72%
	3	2	2	14	5	4	5	3
Interest	6	5	5	6	7	10	9	6
Depreciation	6	8	8	10	11	15	15	16
Profit before Tax	25	15	20	33	17	10	26	22
Tax %	29.69%	30.58%	30.72%	22.70%	31.43%	35.74%	28.47%	29.41%
Net Profit	18	10	14	25	11	6	19	15
EPS	59.03	33.68	44.84	83.76	37.92	30.08	66.51	—
Dividend Payout %	2.54%	0.00%	3.35%	1.79%	3.96%	4.99%	2.26%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 6%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 15%
3 Years:: -7%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: 10%
3 Years:: 7%
Last Year:: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3	3	3	3	3	3	3
Minority Interest	0	0	0	13	20	17	15
	103	113	126	149	166	174	194
	46	64	70	79	100	82	70
Trade Payables	98	49	67	78	60	59	53
	26	27	41	42	51	60	63
Total Liabilities	276	256	307	364	398	395	399
	117	124	130	142	228	223	232
Capital Work in Progress	3	16	38	51	1	6	0
	81	64	62	85	86	81	67
	0	0	0	0	0	51	69
Cash & Bank	3	8	11	4	4	1	2
	72	44	66	82	78	31	29
Total Assets	276	256	307	364	398	395	399

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	37	18	40	-4	18	24	34
Cash from Investing	-44	-27	-26	-7	-31	-18	-15
Cash from Financing	15	12	-3	11	17	-7	-19
	1	-0	6	-8	0	-1	-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.41	71.41	71.41	71.41	71.41	71.80	72.11	72.11
	0.02	0.00	0.00	0.03	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.03	0.29	0.30	0.31
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	28.57	28.59	28.59	28.56	28.57	27.91	27.60	27.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Copy of Newspaper Publication

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication for AGM notice

2026-09-08

Shareholders meeting

2026-09-08 - HALEOS LABS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-05

General Updates

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange about Events Calendar (AGM)

2026-09-05

Record Date

2026-09-05 - HALEOS LABS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.

2026-09-01

Shareholders meeting

2026-09-01 - HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

2026-08-24

Updates

2026-08-24 - HALEOS LABS LIMITED has informed the Exchange regarding 'Communication To Shareholders (TDS Related)'.

2026-08-07

Copy of Newspaper Publication

2026-08-07 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

2026-08-05

Updates

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.

2026-08-05

Change in Director(s)

2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding Change in Director(s) of the company.